Source: https://tradeasduck.com/ideas/bntx/
Retrieved: 2026-11-19

[Archive](https://tradeasduck.com/ideas/) › BNTX

# BNTX trade ideas: every closed DuckWise idea on BioNTech SE

DuckWise has published 2 ideas on BioNTech SE (BNTX, Stock) that have closed between January 2021 and November 2021. Each is listed below with the levels published before the position was taken and its result at close — 2 in profit, 0 at a loss.

**2** closed ideas

**2 / 0** in profit / at a loss

**+31.84%** average result

**95 days** typical holding period

| Opened | Closed | Side | Entry | Stop | Projection | Close | Result | Days |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2021 | Nov 26, 2021 | Long | 281.94 | — | 334 | 350.57 | +24.34% | 24 |
| Jan 11, 2021 | Apr 16, 2021 | Long | 108.45 | — | 146.50 | 151.10 | +39.33% | 95 |

Prices in US dollars. Prices are as traded on the day. Result is the price change from the published entry to the published close plus dividends received while the idea was held (paid, for shorts), before fees, taxes and slippage. [How results are counted](https://tradeasduck.com/methodology/).

## BNTX questions and answers

### Has DuckWise published trade ideas on BNTX?

Yes. DuckWise has published 2 ideas on BioNTech SE (BNTX) that closed between January 2021 and November 2021: 2 closed in profit and 0 at a loss. The average result was +31.84% from the published entry to the published close, dividends included.

### What was the latest closed DuckWise idea on BNTX?

A long idea opened on November 2, 2021 with an entry of $281.94 and a price projection of $334.00. It closed on November 26, 2021 at $350.57, a result of +24.34% after 24 days.

### How long did DuckWise hold its BNTX ideas?

The typical BNTX idea was held about 95 days from entry to close. DuckWise ideas are swing and position trades, not day trades.

### Is there an open DuckWise idea on BNTX right now?

Not at the moment. When DuckWise publishes a new idea on BNTX, app subscribers get a push notification; it appears on this page once it closes.

### Is this page a stock forecast for BNTX or a recommendation to buy it?

No. This page records closed ideas only. Each price projection was a published level for a model idea, not a forecast of where BNTX will trade. The research is general and impersonal, not a recommendation to buy or sell BNTX or any other security.

## More trade ideas on the record
- [BLK](https://tradeasduck.com/ideas/blk/) BlackRock, Inc. · 1 idea
- [BLUE](https://tradeasduck.com/ideas/blue/) bluebird bio, Inc. · 1 idea
- [BMY](https://tradeasduck.com/ideas/bmy/) Bristol-Myers Squibb Company · 2 ideas
- [BRK.B](https://tradeasduck.com/ideas/brk.b/) Berkshire Hathaway Inc. New · 1 idea
- [BTC](https://tradeasduck.com/ideas/btc/) Bitcoin · 6 ideas
- [CAT](https://tradeasduck.com/ideas/cat/) Caterpillar, Inc. · 1 idea
- [AMZN](https://tradeasduck.com/ideas/amzn/) Amazon.com, Inc. · 25 ideas
- [TSLA](https://tradeasduck.com/ideas/tsla/) Tesla, Inc. · 22 ideas
- [CRM](https://tradeasduck.com/ideas/crm/) Salesforce, Inc. · 18 ideas
- [LRCX](https://tradeasduck.com/ideas/lrcx/) Lam Research Corporation · 16 ideas
- [GOOG](https://tradeasduck.com/ideas/goog/) Alphabet Inc. · 15 ideas
- [ON](https://tradeasduck.com/ideas/on/) ON Semiconductor Corporation · 15 ideas
- [AAPL](https://tradeasduck.com/ideas/aapl/) Apple Inc. · 14 ideas
- [AMD](https://tradeasduck.com/ideas/amd/) Advanced Micro Devices, Inc. · 14 ideas

[Every ticker in the archive](https://tradeasduck.com/ideas/) · [Track record by year](https://tradeasduck.com/)

## About BioNTech SE

BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. Does not pay dividends.

These are closed ideas, published for the record. They are general and impersonal research, not a recommendation to buy or sell BNTX or any other security.

---
Model-portfolio results calculated from published entry and close levels plus dividends — not the returns of any real account; fees, taxes and slippage are not included; past results are not a reliable indicator of future results. General, impersonal research — not investment advice and not a recommendation to buy or sell any security.
